Correlation Between Kiromic Biopharma and Therasense
Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and Therasense at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and Therasense into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiromic Biopharma and Therasense, you can compare the effects of market volatilities on Kiromic Biopharma and Therasense and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of Therasense. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and Therasense.
Diversification Opportunities for Kiromic Biopharma and Therasense
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Kiromic and Therasense is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and Therasense in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Therasense and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with Therasense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Therasense has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and Therasense go up and down completely randomly.
Pair Corralation between Kiromic Biopharma and Therasense
If you would invest 0.01 in Therasense on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Therasense or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Kiromic Biopharma vs. Therasense
Performance |
| Timeline |
| Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Therasense |
Kiromic Biopharma and Therasense Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiromic Biopharma and Therasense
The main advantage of trading using opposite Kiromic Biopharma and Therasense positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, Therasense can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Therasense will offset losses from the drop in Therasense's long position.| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
| Therasense vs. Rigel Pharmaceuticals | Therasense vs. Geron | Therasense vs. Verastem | Therasense vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |